**Core Concept**
The question tests knowledge of the drug of choice (DOC) for managing pustular psoriasis in a pregnant woman, specifically during the 2nd trimester. **Pustular psoriasis** is a rare but severe form of **psoriasis** characterized by the appearance of pus-filled blisters. Management during pregnancy requires careful consideration of both efficacy and fetal safety.

**Why the Correct Answer is Right**
Given the severity of pustular psoriasis and its potential to cause significant morbidity, treatment must be effective yet safe for both mother and fetus. The correct answer is not provided, but typically, for pustular psoriasis in pregnancy, especially in the second trimester, **cyclosporine** might be considered due to its rapid onset of action and the fact that it is sometimes used in pregnancy for severe cases when benefits outweigh the risks.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's challenging to give a precise reason, but generally, any option that is not safe in pregnancy or not effective for pustular psoriasis would be incorrect.
**Option B:** Similarly, without specifics, we can say that an ineffective or teratogenic drug would be an incorrect choice.
**Option C:** This option would be incorrect if it represented a drug contraindicated in pregnancy or one that is not typically used for pustular psoriasis.
**Option D:** Again, without the option, we can infer that an incorrect choice would be one that does not balance efficacy with fetal safety.

**Clinical Pearl / High-Yield Fact**
In managing psoriasis in pregnancy, it's crucial to weigh the risks and benefits of each medication, considering both the control of the disease and the safety of the fetus. **Methotrexate**, for example, is contraindicated in pregnancy due to its teratogenic effects.

**Correct Answer:** Correct Answer: C. Cyclosporine.